智通财经APP讯，希玛医疗(03309)发布截至2024年12月31日止年度的全年业绩，收益19.13亿港元，同比减少0.56%;权益持有人应占亏损1.35亿港元，上年同期权益持有人应占溢利6199.8万港元，同比盈转亏;每股基本亏损10.96港仙;拟派发末期股息每股2港仙。
公告称，收益减少乃由于以下各项的综合影响：2024年的核心医疗服务收益(包括提供眼科服务、提供牙科及其他医疗服务以及销售视力辅助产品)创下新高，由2023年的19.05亿港元增长0.5%至19.13亿港元，但被销售COVID-19相关医疗耗材的收益由2023年的1940万港元减少至2024年的零抵销部分增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.